Literature DB >> 447716

Acetylcholine receptor degradation in adult rat diaphragms in organ culture and the effect of anti-acetylcholine receptor antibodies.

J P Merlie, S Heinemann, J M Lindstrom.   

Abstract

Acetylcholine receptor located at the neuromuscular synapse of normal innervated adult muscle fibers is extremely stable metabolically. We have studied the kinetics of receptor degradation in both normal innervated and denervated rat diaphragms in organ culture. These studies show that degradation of receptor-bound 125I-alpha-bungarotoxin is a valid measure of junctional receptor degradation. Degradation of junctional receptor is similar or identical to degradation of extrajunctional receptor in many ways: 1) both require energy, 2) both are inhibited by specific lysosomal protease inhibitors, 3) both are inhibited by treatment with colchicine, and 4) both are stimulated by treatment with anti-acetylcholine receptor antibodies. The one important distinction between degradation of junctional and extrajunctional receptor is a 10-fold difference in rate constant for the process.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447716

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Immunopathologic events at the endplate in myasthenia gravis.

Authors:  T Ashizawa; S H Appel
Journal:  Springer Semin Immunopathol       Date:  1985

Review 2.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  Affinity chromatography and immunosorption with acetylcholine receptor attached to nylon tubes.

Authors:  B H Yang; P V Sundaram; A Maelicke
Journal:  Biochem J       Date:  1981-11-01       Impact factor: 3.857

Review 4.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Denervation increases the degradation rate of acetylcholine receptors at end-plates in vivo and in vitro.

Authors:  S Bevan; J H Steinbach
Journal:  J Physiol       Date:  1983-03       Impact factor: 5.182

6.  Experimental autoimmune myasthenia gravis.

Authors:  J Lindstrom
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

7.  Crosslinkage and visualization of acetylcholine receptors on myotubes with biotinylated alpha-bungarotoxin and fluorescent avidin.

Authors:  D Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

8.  Cellular and humoral immunity to acetylcholine receptor in myasthenia gravis.

Authors:  B M Conti Tronconi; A Scotti; A Brigonzi; E Sher; G Fumagalli; D Peluchetti; F Clementi
Journal:  Ital J Neurol Sci       Date:  1982-03

9.  Neuromuscular junctions and alpha-bungarotoxin-binding sites in denervated and contralateral cat skeletal muscles.

Authors:  J H Steinbach
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

10.  Overexpression of myogenin in muscles of transgenic mice: interaction with Id-1, negative crossregulation of myogenic factors, and induction of extrasynaptic acetylcholine receptor expression.

Authors:  K Gundersen; I Rabben; B J Klocke; J P Merlie
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.